Conference Coverage
Conference Coverage
Pregnancies with low anti-SSA/Ro autoantibody levels: Forgo fetal heart rhythm monitoring?
The ongoing prospective multicenter trial is the largest of its kind.
Conference Coverage
Alpha-gal syndrome: Red meat is ‘just the beginning,’ expert says
“We are seeing increasing diagnoses of AGS in places that are not, perhaps, where we first thought this allergy existed.”
Conference Coverage
CPPD nomenclature is sore subject for gout group
G-CAN hopes to standardize terminology and finally oust ‘pseudo’ vernacular.
Conference Coverage
Semaglutide ‘a new pathway’ to CVD risk reduction: SELECT
The SELECT trial was “a turning point in the treatment of obesity and a call to action.”
Latest News
Prurigo nodularis diagnosis delay in skin of color gains added significance
Given the expanding array of therapies, the message of considering prurigo nodularis in Black patients in order to accelerate the time to...
Conference Coverage
Gout: Studies support early use of urate-lowering therapy, warn of peripheral arterial disease
Urate-lowering drugs might be OK early on; gout may boost peripheral arterial disease.
Conference Coverage
AI algorithm aids egg retrieval date during fertility treatment cycles
The predictions derived from this study could improve various aspects of fertility treatments and related procedures.
Latest News
The challenges of palmoplantar pustulosis and other acral psoriatic disease
Dermatologists are using a variety of treatments for palmoplantar pustulosis, with no clear first-line choices.
Latest News
Risk calculator for early-stage CKD may soon enter U.S. market
Klinrisk, which estimates an adult’s risk for CKD progression from 20 lab values, may spur more targeted, intensified treatment.
Latest News
MASLD, MASH projected to grow by 23% in the U.S. through 2050
“In the absence of effective treatments, health systems should plan for large increases in the number of liver cancer cases and the need for liver...
Conference Coverage
Newer antiobesity meds lower the body’s defended fat mass
“These medications change [the defended fat mass] to something that is more normal, rather than ‘fixing’ it.”